Carmentix
Singapore
About Carmentix
Carmentix enables early prevention of preterm birth through prediction. It develops a novel biomarker prognostic panel for preterm birth. They reduce the number of preterm birth in the global setting by establishing biomolecular tools that will alert clinicians for the risk of preterm birth weeks before symptoms occur.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.5M
- Last round: Series Unknown (Jun 2015)
- Website: carmentix.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/carmentix-2747327 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.